<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39401963</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Impact of the COVID-19 pandemic on time to treatment, treatment patterns and outcomes among patients with acute coronary syndrome in Yogyakarta, Indonesia: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>e079060</StartPage><MedlinePgn>e079060</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e079060</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2023-079060</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to evaluate the impact of the COVID-19 pandemic on the management of acute coronary syndrome (ACS) in Yogyakarta, Indonesia with respect to time to treatment, treatment pattern and treatment outcome.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This is a retrospective cohort study in which medical records of hospitalised patients with ACS were reviewed.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Three hospitals in Yogyakarta, Indonesia.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Patients hospitalised with ACS during two pandemic periods (first pandemic period: March-August 2020; second pandemic period: March-August 2021) and prepandemic period (March-August 2019).</AbstractText><AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">Time to treatment, treatment pattern and treatment outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 598 patients with ST-elevation myocardial infarction (STEMI) and 615 with non-ST-elevation ACS were identified. Of these, 313, 484 and 416 were identified during the prepandemic period, first pandemic period and second pandemic period, respectively. For STEMI, the proportion of patients with a delay from symptom onset to first medical contact (FMC) was significantly higher during the second pandemic period as compared with the prepandemic period (47.7% vs 32.0%, OR=1.84, 95% CI 1.18, 2.85). The proportion of patients with STEMI with delayed door-to-balloon (D2B) time was significantly higher during the second pandemic period as compared with the prepandemic period (99.4% vs 92.9%, OR=13.08, 95% CI 1.57, 108.73). Significantly longer mean total ischaemic time (45.85 hours vs 30.29 hours, mean difference=14.56, 95% CI 1.85, 27.28) was observed among patients with STEMI during the second year of the pandemic as compared with the prepandemic period. No significant differences between the prepandemic period and the first pandemic period were found in terms of proportion of patients with STEMI with a delay in time from symptom onset to FMC, delayed D2B time and total ischaemic time. Only Global Registry of Acute Coronary Events risk score (OR=1.04, 95% CI 1.03, 1.05) was a significant predictor of in-hospital mortality in the multivariate analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study suggests a significant impact of the COVID-19 pandemic on time to treatment among patients with ACS. Health systems need to be well prepared to support effective and timely treatment of patients with ACS during future crisis.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dewi</LastName><ForeName>Pramitha Esha Nirmala</ForeName><Initials>PEN</Initials><AffiliationInfo><Affiliation>Doctor of Philosophy Program in Social, Economic, and Administrative Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy Profession, Faculty of Medicine and Health Sciences, Universitas Muhammadiyah Yogyakarta, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Youngkong</LastName><ForeName>Sitaporn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunantiwat</LastName><ForeName>Montaya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nathisuwan</LastName><ForeName>Surakit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thavorncharoensap</LastName><ForeName>Montarat</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8256-2167</Identifier><AffiliationInfo><Affiliation>Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand montarat.tha@mahidol.ac.th.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007214" MajorTopicYN="N" Type="Geographic">Indonesia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054058" MajorTopicYN="Y">Acute Coronary Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="Y">Time-to-Treatment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="N">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072658" MajorTopicYN="N">Non-ST Elevated Myocardial Infarction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">coronary heart disease</Keyword><Keyword MajorTopicYN="N">health services accessibility</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39401963</ArticleId><ArticleId IdType="pmc">PMC11481136</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2023-079060</ArticleId><ArticleId IdType="pii">bmjopen-2023-079060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  WHO Coronavirus (COVID-19) Dashboard. 2022. https://covid19.who.int/ Available.</Citation></Reference><Reference><Citation>Grines CL. SCAI consumer survey comparing fear of COVID-19 versus heart attack or stroke. Catheter Cardiovasc Interv. 2021;97:193–4. doi: 10.1002/ccd.29419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.29419</ArticleId><ArticleId IdType="pmc">PMC7753652</ArticleId><ArticleId IdType="pubmed">33258223</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia S, Stanberry L, Schmidt C, et al. Impact of COVID‐19 pandemic on STEMI care: An expanded analysis from the United States. Cathet Cardio Intervent. 2021;98:217–22. doi: 10.1002/ccd.29154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.29154</ArticleId><ArticleId IdType="pmc">PMC7436427</ArticleId><ArticleId IdType="pubmed">32767652</ArticleId></ArticleIdList></Reference><Reference><Citation>Moynihan R, Sanders S, Michaleff ZA, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11:e045343. doi: 10.1136/bmjopen-2020-045343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045343</ArticleId><ArticleId IdType="pmc">PMC7969768</ArticleId><ArticleId IdType="pubmed">33727273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez B, James S, Agewall S, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2017;39:119–77.</Citation><ArticleIdList><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Jneid H, Addison D, Bhatt DL, et al. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2017;70:2048–90. doi: 10.1016/j.jacc.2017.06.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.06.032</ArticleId><ArticleId IdType="pubmed">28943066</ArticleId></ArticleIdList></Reference><Reference><Citation>Irawati S, Dharma S, Taxis K, et al. Association between Adherence to Guideline-Recommended Preventive Medications and In-Hospital Mortality among Non-Reperfused ST-Elevation Myocardial Infarction Patients Admitted to a Tertiary Care Academic Center in a Developing Country. Glob Heart. 2020;15:8. doi: 10.5334/gh.394.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/gh.394</ArticleId><ArticleId IdType="pmc">PMC7218801</ArticleId><ArticleId IdType="pubmed">32489781</ArticleId></ArticleIdList></Reference><Reference><Citation>Helal A, Shahin L, Abdelsalam M, et al. Global effect of COVID-19 pandemic on the rate of acute coronary syndrome admissions: a comprehensive review of published literature. Open Heart. 2021;8:e001645. doi: 10.1136/openhrt-2021-001645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2021-001645</ArticleId><ArticleId IdType="pmc">PMC8182753</ArticleId><ArticleId IdType="pubmed">34083389</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss P, Carcel C, Hockham C, et al. The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review. Eur Heart J Qual Care Clin Outcomes. 2021;7:18–27. doi: 10.1093/ehjqcco/qcaa084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcaa084</ArticleId><ArticleId IdType="pmc">PMC7665454</ArticleId><ArticleId IdType="pubmed">33151274</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogharab V, Ostovar M, Ruszkowski J, et al. Global burden of the COVID-19 associated patient-related delay in emergency healthcare: a panel of systematic review and meta-analyses. Global Health. 2022;18:58. doi: 10.1186/s12992-022-00836-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12992-022-00836-2</ArticleId><ArticleId IdType="pmc">PMC9175527</ArticleId><ArticleId IdType="pubmed">35676714</ArticleId></ArticleIdList></Reference><Reference><Citation>Beza L, Leslie SL, Alemayehu B, et al. Acute coronary syndrome treatment delay in low to middle-income countries: A systematic review. Int J Cardiol Heart Vasc. 2021;35:100823. doi: 10.1016/j.ijcha.2021.100823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2021.100823</ArticleId><ArticleId IdType="pmc">PMC8233123</ArticleId><ArticleId IdType="pubmed">34195352</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharma S, Juzar DA, Firdaus I, et al. Acute myocardial infarction system of care in the third world. Neth Heart J. 2012;20:254–9. doi: 10.1007/s12471-012-0259-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12471-012-0259-9</ArticleId><ArticleId IdType="pmc">PMC3370084</ArticleId><ArticleId IdType="pubmed">22328356</ArticleId></ArticleIdList></Reference><Reference><Citation>Qanitha A, Uiterwaal CSPM, Henriques JPS, et al. Characteristics and the average 30-day and 6-month clinical outcomes of patients hospitalised with coronary artery disease in a poor South-East Asian setting: the first cohort from Makassar Cardiac Center, Indonesia. BMJ Open. 2018;8:e021996. doi: 10.1136/bmjopen-2018-021996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-021996</ArticleId><ArticleId IdType="pmc">PMC6020938</ArticleId><ArticleId IdType="pubmed">29950477</ArticleId></ArticleIdList></Reference><Reference><Citation>Qanitha A, Uiterwaal CSPM, Henriques JPS, et al. Predictors of medium-term mortality in patients hospitalised with coronary artery disease in a resource-limited South-East Asian setting. Open Heart. 2018;5:e000801. doi: 10.1136/openhrt-2018-000801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2018-000801</ArticleId><ArticleId IdType="pmc">PMC6059341</ArticleId><ArticleId IdType="pubmed">30057767</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharma S, Andriantoro H, Purnawan I, et al. Characteristics, treatment and in-hospital outcomes of patients with STEMI in a metropolitan area of a developing country: an initial report of the extended Jakarta Acute Coronary Syndrome registry. BMJ Open. 2016;6:e012193. doi: 10.1136/bmjopen-2016-012193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-012193</ArticleId><ArticleId IdType="pmc">PMC5013359</ArticleId><ArticleId IdType="pubmed">27580835</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahendradhata Y, Andayani NLPE, Hasri ET, et al. The Capacity of the Indonesian Healthcare System to Respond to COVID-19. Front Public Health. 2021;9:649819. doi: 10.3389/fpubh.2021.649819.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.649819</ArticleId><ArticleId IdType="pmc">PMC8292619</ArticleId><ArticleId IdType="pubmed">34307272</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharma S, Dakota I, Firdaus I, et al. Performance of Primary Angioplasty for STEMI during the COVID-19 Outbreak. Int J Angiol. 2021;30:148–54. doi: 10.1055/s-0041-1727133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1727133</ArticleId><ArticleId IdType="pmc">PMC8159598</ArticleId><ArticleId IdType="pubmed">34054273</ArticleId></ArticleIdList></Reference><Reference><Citation>Firman D, Mangkuanom AS, Iryuza N, et al. Decrease in the Number of Patients Presenting With ST-Segment Elevation Myocardial Infarction Across Catheterization Centers in Indonesia During the Coronavirus Disease 2019 Pandemic. Front Cardiovasc Med. 2021;8:676592. doi: 10.3389/fcvm.2021.676592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.676592</ArticleId><ArticleId IdType="pmc">PMC8418056</ArticleId><ArticleId IdType="pubmed">34490361</ArticleId></ArticleIdList></Reference><Reference><Citation>Edouard M, Hannah R, Lucas RG, et al.   OurWorldinData.org; 2020. Coronavirus pandemic (covid-19)https://ourworldindata.org/coronavirus Available.</Citation></Reference><Reference><Citation>Collet J-P, Thiele H, Barbato E, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2020;42:1289–367. doi: 10.1093/eurheartj/ehaa909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa909</ArticleId><ArticleId IdType="pubmed">32860058</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicent L, Velásquez-Rodríguez J, Valero-Masa MJ, et al. Predictors of high Killip class after ST segment elevation myocardial infarction in the era of primary reperfusion. Int J Cardiol. 2017;248:46–50. doi: 10.1016/j.ijcard.2017.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2017.07.038</ArticleId><ArticleId IdType="pubmed">28942880</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh K, Thombs BD, Bhat U, et al. Long-term significance of Killip class and left ventricular systolic dysfunction. Am J Med. 2008;121:1015–8. doi: 10.1016/j.amjmed.2008.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2008.06.020</ArticleId><ArticleId IdType="pubmed">18954850</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew NWS, Ow ZGW, Teo VXY, et al. The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis. Can J Cardiol. 2021;37:1450–9. doi: 10.1016/j.cjca.2021.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2021.04.003</ArticleId><ArticleId IdType="pmc">PMC8056787</ArticleId><ArticleId IdType="pubmed">33848599</ArticleId></ArticleIdList></Reference><Reference><Citation>Braiteh N, Rehman WU, Alom M, et al. Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York. Am Heart J. 2020;226:147–51. doi: 10.1016/j.ahj.2020.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2020.05.009</ArticleId><ArticleId IdType="pmc">PMC7244433</ArticleId><ArticleId IdType="pubmed">32569892</ArticleId></ArticleIdList></Reference><Reference><Citation>Erol MK, Kayıkçıoğlu M, Kılıçkap M, et al. Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study. Anatol J Cardiol. 2020;24:334–42. doi: 10.14744/AnatolJCardiol.2020.98607.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/AnatolJCardiol.2020.98607</ArticleId><ArticleId IdType="pmc">PMC7724394</ArticleId><ArticleId IdType="pubmed">33122486</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidin M, Lyngå P, Kinch-Westerdahl A, et al. Patient delay prior to care-seeking in acute myocardial infarction during the outbreak of the coronavirus SARS-CoV2 pandemic. Eur J Cardiovasc Nurs. 2021;20:752–9. doi: 10.1093/eurjcn/zvab087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjcn/zvab087</ArticleId><ArticleId IdType="pubmed">34718511</ArticleId></ArticleIdList></Reference><Reference><Citation>Chieffo A, Stefanini GG, Price S, et al. EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. Eur Heart J. 2020;41:1839–51. doi: 10.1093/eurheartj/ehaa381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa381</ArticleId><ArticleId IdType="pmc">PMC7239193</ArticleId><ArticleId IdType="pubmed">32405641</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahuva R, Aoun J, Goel SS. Management of Acute Coronary Syndrome in the COVID Era. Methodist Debakey Cardiovasc J. 2021;17:16–21. doi: 10.14797/mdcvj.1049.</Citation><ArticleIdList><ArticleId IdType="doi">10.14797/mdcvj.1049</ArticleId><ArticleId IdType="pmc">PMC8680070</ArticleId><ArticleId IdType="pubmed">34992720</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameli M, Pastore MC, Mandoli GE, et al. COVID-19 and Acute Coronary Syndromes. Curr Data Future Front Cardiovasc Med. 2021;7 doi: 10.3389/fcvm.2020.593496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.593496</ArticleId><ArticleId IdType="pmc">PMC7876078</ArticleId><ArticleId IdType="pubmed">33585577</ArticleId></ArticleIdList></Reference><Reference><Citation>Henein MY, Bytyçi I, Nicoll R, et al. Obesity Strongly Predicts COVID-19-Related Major Clinical Adverse Events in Coptic Clergy. J Clin Med. 2021;10:2752. doi: 10.3390/jcm10132752.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132752</ArticleId><ArticleId IdType="pmc">PMC8269321</ArticleId><ArticleId IdType="pubmed">34206658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng S, Juzar DA. Challenges in STEMI Management during COVID-19 Pandemic. Indones J Cardiol. 2020;41</Citation></Reference><Reference><Citation>Esteves V, Zukowski CN, FAd L, et al. The Association between Covid-19 and ST Elevation Myocardial Infarction: Variable Clinical Presentations on a Case Report Series. Int J Cardiovasc Sci. 2020;33:429–35.</Citation></Reference><Reference><Citation>Daoulah A, Hersi AS, Al-Faifi SM, et al. STEMI and COVID-19 Pandemic in Saudi Arabia. Curr Probl Cardiol. 2021;46:100656. doi: 10.1016/j.cpcardiol.2020.100656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100656</ArticleId><ArticleId IdType="pmc">PMC7374127</ArticleId><ArticleId IdType="pubmed">32839042</ArticleId></ArticleIdList></Reference><Reference><Citation>Araiza-Garaygordobil D, Montalto C, Martinez-Amezcua P, et al. Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study. QJM. 2021;114:642–7. doi: 10.1093/qjmed/hcab013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab013</ArticleId><ArticleId IdType="pmc">PMC7928691</ArticleId><ArticleId IdType="pubmed">33486512</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramudyo M, Yahya Af Fau - Martanto E, Martanto E Fau - Tiksnadi BB, et al. Predictors of In-Hospital Mortality in Patients with Acute Coronary Syndrome in Hasan Sadikin Hospital. Acta Med Indones. 2022;54:379–88.</Citation><ArticleIdList><ArticleId IdType="pubmed">36156467</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernández-Martínez NF, Ortiz-González-Serna R, Serrano-Ortiz Á, et al. Sex Differences and Predictors of In-Hospital Mortality among Patients with COVID-19: Results from the ANCOHVID Multicentre Study. Int J Environ Res Public Health. 2021;18:9018. doi: 10.3390/ijerph18179018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18179018</ArticleId><ArticleId IdType="pmc">PMC8431708</ArticleId><ArticleId IdType="pubmed">34501608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali SF, Smith EE, Bhatt DL, et al. Paradoxical association of smoking with in-hospital mortality among patients admitted with acute ischemic stroke. J Am Heart Assoc. 2013;2:e000171. doi: 10.1161/JAHA.113.000171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000171</ArticleId><ArticleId IdType="pmc">PMC3698779</ArticleId><ArticleId IdType="pubmed">23782919</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams MJA, Lee M, Alfadhel M, et al. Obesity and All Cause Mortality Following Acute Coronary Syndrome (ANZACS-QI 53) Heart Lung Circ. 2021;30:1854–62. doi: 10.1016/j.hlc.2021.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2021.04.014</ArticleId><ArticleId IdType="pubmed">34083149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta T, Kolte D, Khera S, et al. Smoker’s Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. J Am Heart Assoc. 2016;5:e003370. doi: 10.1161/JAHA.116.003370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.003370</ArticleId><ArticleId IdType="pmc">PMC4843594</ArticleId><ArticleId IdType="pubmed">27107131</ArticleId></ArticleIdList></Reference><Reference><Citation>Chotechuang Y, Phrommintikul A, Muenpa R, et al. The prognostic utility of GRACE risk score in predictive cardiovascular event rate in STEMI patients with successful fibrinolysis and delay intervention in non PCI-capable hospital: a retrospective cohort study. BMC Cardiovasc Disord. 2016;16:212. doi: 10.1186/s12872-016-0383-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-016-0383-3</ArticleId><ArticleId IdType="pmc">PMC5100095</ArticleId><ArticleId IdType="pubmed">27821064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofidis G, Otountzidis N, Stalikas N, et al. Association of GRACE Risk Score with Coronary Artery Disease Complexity in Patients with Acute Coronary Syndrome. J Clin Med. 2021;10:2210. doi: 10.3390/jcm10102210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10102210</ArticleId><ArticleId IdType="pmc">PMC8160761</ArticleId><ArticleId IdType="pubmed">34065227</ArticleId></ArticleIdList></Reference><Reference><Citation>Solano-López J, Zamorano JL, Pardo Sanz A, et al. Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak. Rev Esp Cardiol . 2020;73:985–93. doi: 10.1016/j.recesp.2020.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.recesp.2020.07.023</ArticleId><ArticleId IdType="pmc">PMC7832619</ArticleId><ArticleId IdType="pubmed">32839121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wójcik M, Karpiak J, Zaręba L, et al. The GRACE risk score in patients with ST-segment elevation myocardial infarction and concomitant COVID-19. Arch Med Sci Atheroscler Dis . 2022;7:e116–23. doi: 10.5114/amsad/152107.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/amsad/152107</ArticleId><ArticleId IdType="pmc">PMC9487828</ArticleId><ArticleId IdType="pubmed">36158064</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad M, Kennedy KF, Imran H, et al. Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction. JAMA. 2021;326:1940–52. doi: 10.1001/jama.2021.18890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.18890</ArticleId><ArticleId IdType="pmc">PMC8596198</ArticleId><ArticleId IdType="pubmed">34714327</ArticleId></ArticleIdList></Reference><Reference><Citation>Primessnig U, Pieske BM, Sherif M. Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemic. ESC Heart Fail. 2021;8:333–43. doi: 10.1002/ehf2.13075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13075</ArticleId><ArticleId IdType="pmc">PMC7835606</ArticleId><ArticleId IdType="pubmed">33283476</ArticleId></ArticleIdList></Reference><Reference><Citation>Grech N, Xuereb R, England K, et al. When the patients stayed home: the impact of the COVID-19 pandemic on acute cardiac admissions and cardiac mortality in Malta. Z Gesundh Wiss. 2022;30:1725–31. doi: 10.1007/s10389-021-01520-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10389-021-01520-2</ArticleId><ArticleId IdType="pmc">PMC7986642</ArticleId><ArticleId IdType="pubmed">33777653</ArticleId></ArticleIdList></Reference><Reference><Citation>Cader FA, Banerjee S, Gulati M. Sex Differences in Acute Coronary Syndromes: A Global Perspective. J Cardiovasc Dev Dis. 2022;9:239. doi: 10.3390/jcdd9080239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd9080239</ArticleId><ArticleId IdType="pmc">PMC9409655</ArticleId><ArticleId IdType="pubmed">36005403</ArticleId></ArticleIdList></Reference><Reference><Citation>Sella YO, Manistamara H, Apriliawan S, et al. Characteristic differences of chest pain in male and female patients with acute coronary syndrome: A pilot study. J Public Health Res. 2021;10:2242. doi: 10.4081/jphr.2021.2242.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/jphr.2021.2242</ArticleId><ArticleId IdType="pmc">PMC8129765</ArticleId><ArticleId IdType="pubmed">33855424</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>